MondayAug 14, 2023 12:50 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q2 2023 Results, Presents Updated Findings from Potentially Pivotal Study of Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced its financial results for the quarter ended June 30, 2023, provided a corporate update and reiterated upcoming milestones. “We are approaching the most important milestone to date since we launched CNS Pharma. We are just a few months away from reporting topline results from our Berubicin potentially pivotal study interim analysis and, although we do not know what the data looks like at this time, we remain hopeful as we also approach…

Continue Reading

MondayAug 14, 2023 11:15 am

BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) Alpaca-Derived Nanobodies for Potential Treatment of Diseases Underserved by Current Therapeutics

Innovative nanobody therapeutics could deliver substantial competitive advantages in both cost and efficacy when compared to traditional monoclonal antibody therapies The biologics market was valued at $366.5 billion in 2021 and is expected to grow to a value of $719.94 billion by 2030 The monoclonal antibodies market was valued at $210.06 billion in 2022, and it is expected to reach $494.53 billion by 2030 The nanobody market was valued $237.1 million in 2021 and is expected reach a value of $1.07 billion by 2028 BiondVax is uniquely positioned to rapidly advance from R&D towards commercialization BiondVax Pharmaceuticals (NASDAQ: BVXV), a…

Continue Reading

MondayAug 14, 2023 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Moving to Become the Leading Metal Separation Products and Services Provider, One Investment at a Time

Ucore recently announced the closing of the first tranche of its previously announced private placement offering of units of the company On June 6, the company announced that the U.S. DOD had awarded it a $4 million project grant Together, these moves bolster Ucore’s working capital and continue to stamp its position as a leader in its space Through its investments, Ucore is inching closer to taking over the global rare earth elements market, which is expected to hit $5.6 billion by 2025 Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a company engaged in the exploration for and separation and…

Continue Reading

MondayAug 14, 2023 9:45 am

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Unique Strategy Ideally Suited for Growing Tellurium Sector

Recent report projects estimated growth of tellurium market at CAGR of 3.41% between 2022 and 2027 Growth is tied to increased demand from the consumer electronics industry Company’s unique approach offers significant advantages over larger mines With recent market projections showing steady growth in the tellurium market (https://ibn.fm/11Lg4), First Tellurium’s (CSE: FTEL) (OTCQB: FSTTF) small-mine, phased-approach strategy is sure to strengthen the company’s position in the growing space. “The tellurium market is estimated to grow at a CAGR of 3.41% between 2022 and 2027,” a 2023 Technavio analysis study reported. “The size of the market is forecast to increase by 83.72 MT.” The report…

Continue Reading

MondayAug 14, 2023 9:00 am

Renovaro BioSciences Inc. (NASDAQ: RENB) Is ‘One to Watch’

In June 2023, Renovaro announced that a potential IND application for its innovative cancer platform is on track for early 2024 FDA submission The company in March 2023 announced proof-of-concept for its proprietary technology to treat pancreatic tumors In August 2023, Renovaro announced its entry into a Letter of Intent to merge with GEDi Cube International Ltd. with the aim of accelerating diagnosis, enhancing treatment effectiveness, discovering new therapies, and expanding access to life-saving technologies for cancer and other diseases As of August 2023, Renovaro has raised total cash of $82.7 million The company’s IP portfolio covering gene and gene-modified…

Continue Reading

FridayAug 11, 2023 3:45 pm

QualityStocksNewsBreaks – Ucore Rare Metals Inc.’s (TSX.V: UCU) (OTCQX: UURAF) RapidSX(TM) Combines Time-Proven Chemistry with Novel Platform

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is focused on a vision to become a leading advanced technology company, providing best-in-class metal separation products and services to the mining and mineral extraction industry. The company intends to deploy its RapidSX(TM) technology in pursuit of a critical metals supply chain independent of China and Western original equipment manufacturers – most notably in the automotive industry and renewable energy. “Although not a new technology, RapidSX(TM) combines the time-proven chemistry of conventional solvent extraction (‘SX’) with a new column-based platform that significantly reduces time to completion and plant footprint and potentially lowers capital…

Continue Reading

FridayAug 11, 2023 3:00 pm

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Monitoring Developments in Commercial Vehicles Industry as Part of Overall Focus to Revolutionize Cross-Border Shipping

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a tech company revolutionizing cross-border shipping by offering carriers increased growth opportunities and shippers with flexibility, visibility and simplicity, is closely monitoring speed limiter directives on commercial vehicles. “As a company heavily invested in the industry, such directives could impact its performance and service delivery,” a recent article reads. “The Federal Motor Carrier Safety Administration (‘FMCSA’) proposed a rule that would mandate speed limiters for most commercial vehicles. While the exact speed has not been confirmed, safety groups have proposed a 60 mph limit for heavy-duty trucks. This is not the first time such a…

Continue Reading

FridayAug 11, 2023 2:34 pm

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Q2 Financial Report, Corporate Update

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, is reporting on its financial results for the second quarter ended June 30, 2023; the report also included a business update. Highlights of the report include R&D expenses for the quarter totaled $1.45 million compared with $1.97 million for the same period in 2022; marketing, general and administrative expenses for the quarter reached $1.14 million compared with $1.29 million for the 2022 period; total operating expenses for the quarter amounted to $2.56 million compared with…

Continue Reading

FridayAug 11, 2023 2:25 pm

QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Releases Updated Information Regarding SRM Entertainment Spin-Off, Closes on Safety Shot Acquisition

Jupiter Wellness (NASDAQ: JUPW), a wellness company focused on hair metabolism and skin therapies, has released the updated payment date for the distribution of shares of common stock, par value $0.0001 per share, of SRM Entertainment Inc. SRM Entertainment is currently a majority-owned subsidiary of Jupiter Wellness. According to the announcement, the date to effect the spin-off of the SRM business is planned for Aug. 14, 2023; the payment date remains subject to SRM’s Registration Statement on Form S-1 being declared effective by the U.S. Securities and Exchange Commission. “In the event that such registration statement is not declared effective…

Continue Reading

FridayAug 11, 2023 2:11 pm

QualityStocksNewsBreaks – GEMXX Corporation (GEMZ) Reports on Form 1A Qualification, Shares Update

GEMXX (OTC: GEMZ), a leader in the Ammolite gemstone mine-to-market segment, has announced full qualification of Tier 1, Form 1A registration statement and has released an update on certain achievements. According to the announcement, GEMXX’s Form 1-A to raise up to $6 million is fully qualified. In addition, company officials noted that the company is working with several parties that are interested in participating in the Regulation-A financing; funds from that financing will be used for Ammolite mining expansion, increased production and diversification of operations. The company’s M&A team is also focused on further strengthening the business through strategic partnerships and…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered